Claudin 18 (43–14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapyRiley J. Arseneau, Thomas Arnason, Ravi Ramjeesingh et al.|Translational Oncology|2025Cited by 11
Abstract B028: Claudin-18 expression (using the 43-14A antibody kit) in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for immunotherapy with zolbetuximabRiley J. Arseneau, Thomas Arnason, Emma Kempster et al.|Cancer Immunology Research|2024Cited by 0